MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetes
miR-30促进脂肪酸β-氧化和内皮细胞功能障碍，并且是糖尿病临床前模型中冠状动脉微血管功能障碍的循环生物标志物。
期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-022-01458-z
Veitch, Shawn; Njock, Makon-Sébastien; Chandy, Mark; Siraj, M Ahsan; Chi, Lijun; Mak, HaoQi; Yu, Kai; Rathnakumar, Kumaragurubaran; Perez-Romero, Carmina Anjelica; Chen, Zhiqi; Alibhai, Faisal J; Gustafson, Dakota; Raju, Sneha; Wu, Ruilin; Zarrin Khat, Dorrin; Wang, Yaxu; Caballero, Amalia; Meagher, Patrick; Lau, Edward; Pepic, Lejla; Cheng, Henry S; Galant, Natalie J; Howe, Kathryn L; Li, Ren-Ke; Connelly, Kim A; Husain, Mansoor; Delgado-Olguin, Paul; Fish, Jason E
